BCL2L1 and acute myeloid leukemia: Accordingly, it is worth underscoring that in each of ourindependently-evolved ABT-199-resistant AML lines, acquired resistance wasaccompanied by upregulation of MCL-1 and/or BCL-XL—anti-apoptoticBCL-2 family proteins not targeted by ABT-199.